NEUROTOXICITY OF INTRAVENTRICULARLY ADMINISTERED ALPHA-INTERFERON FOR LEPTOMENINGEAL DISEASE

被引:1
|
作者
MEYERS, CA [1 ]
OBBENS, EAMT [1 ]
SCHEIBEL, RS [1 ]
MOSER, RP [1 ]
机构
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,NEUROSURG SECT,HOUSTON,TX 77030
关键词
D O I
10.1002/1097-0142(19910701)68:1<88::AID-CNCR2820680118>3.0.CO;2-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nine patients with leptomeningeal disease are reported who were treated with intraventricular alpha-interferon (alpha-IFN). In seven of these patients, a progressive vegetative state developed during treatment. The patients became unresponsive to verbal commands but opened their eyes with auditory or tactile stimulation. It took an average of 3 weeks for these patients to become verbally responsive after treatment was discontinued. Electroencephalographic findings showed evidence of irritative involvement of the deep midline nuclei in 80% of patients. Periventricular white matter changes developed during treatment in three of six patients who underwent computed tomographic scans. All patients with this severe neurotoxicity received whole-brain irradiation before treatment. Possible mechanisms for the development of this neurotoxic syndrome are discussed. The neurotoxicity of alpha-IFN and brain irradiation may be additive, suggesting a cautious approach when using this combination for treatment.
引用
收藏
页码:88 / 92
页数:5
相关论文
共 50 条
  • [31] ALPHA-INTERFERON - A LOOK TO THE FUTURE
    BONNEM, EM
    INVESTIGATIONAL NEW DRUGS, 1987, 5 : S65 - S75
  • [32] ALPHA-INTERFERON AND LYMPHOID HEMOPATHIES
    FLANDRIN, G
    ANNALES DE MEDECINE INTERNE, 1988, 139 (08): : 530 - 533
  • [33] ALPHA-INTERFERON IN THROMBOCYTOPENIC PURPURA
    TAILLAN, B
    FUZIBET, JG
    PESCE, A
    VINTI, H
    SANDERSON, F
    DUJARDIN, P
    CASSUTO, JP
    LANCET, 1988, 2 (8603): : 170 - 170
  • [34] ALPHA-INTERFERON INDUCED DYSTHYROIDISM
    CHEDIN, P
    CHANSON, P
    DURANTEAU, L
    GUILLAUSSEAU, PJ
    LUBETZKI, J
    PRESSE MEDICALE, 1994, 23 (36): : 1659 - 1663
  • [35] Psoriatic arthritis and alpha-interferon
    Olivieri, I
    Padula, A
    Ciancio, G
    La Civita, L
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2001, 30 (03) : 175 - 175
  • [36] TREATMENT OF HBV WITH ALPHA-INTERFERON
    BROOK, MG
    CHAN, G
    YAP, I
    KARAYIANNIS, P
    LEVER, AML
    JACYNA, M
    MAIN, J
    THOMAS, HC
    GUT, 1989, 30 (05) : A707 - A707
  • [37] Alpha-interferon (IFN-alpha) treatment Behcet's disease (BD).
    ODuffy, JD
    Matteson, E
    Calamia, K
    Cohen, S
    Jorizzo, J
    Herman, D
    Goronzy, J
    Kokmen, E
    Weyand, C
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1198 - 1198
  • [38] ALPHA-INTERFERON IN PATIENTS WITH PROGRESSIVE AND OR RECURRENT HODGKINS-DISEASE
    KOZINER, B
    EUROPEAN JOURNAL OF CANCER, 1991, 27 : S79 - S80
  • [39] IMMUNE EFFECTS OF ALPHA-INTERFERON IN CHRONIC LIVER-DISEASE
    PETERS, M
    WALLING, DM
    WAGGONER, J
    AVIGAN, MI
    SJOGREN, M
    HOOFNAGLE, JH
    JOURNAL OF HEPATOLOGY, 1986, 3 : S283 - S289
  • [40] Biodistribution and Dosimetry of Intraventricularly Administered 124I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors
    Pandit-Taskar, Neeta
    Zanzonico, Pat B.
    Kramer, Kim
    Grkovski, Milan
    Fung, Edward K.
    Shi, Weiji
    Zhang, Zhigang
    Lyashchenko, Serge K.
    Fung, Alex M.
    Pentlow, Keith S.
    Carrasquillo, Jorge A.
    Lewis, Jason S.
    Larson, Steven M.
    Cheung, Nai-Kong, V
    Humm, John L.
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (12) : 1794 - 1801